Related Experiment Video
Updated: Jul 16, 2025

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
Metastasis organotropism in colorectal cancer: advancing toward innovative therapies
Kai He1,2, Zhihan Wang2, Maochao Luo2
1School of Basic Medical Sciences and State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Abstract:
Distant metastasis remains a leading cause of mortality among patients with colorectal cancer (CRC). Organotropism, referring to the propensity of metastasis to target specific organs, is a well-documented phenomenon in CRC, with the liver, lungs, and peritoneum being preferred sites. Prior to establishing premetastatic niches within host organs, CRC cells secrete substances that promote metastatic organotropism. Given the pivotal role of organotropism in CRC metastasis, a comprehensive understanding of its molecular underpinnings is crucial for biomarker-based diagnosis, innovative treatment development, and ultimately, improved patient outcomes. In this review, we focus on metabolic reprogramming, tumor-derived exosomes, the immune system, and cancer cell-organ interactions to outline the molecular mechanisms of CRC organotropic metastasis. Furthermore, we consider the prospect of targeting metastatic organotropism for CRC therapy.
Insights
Distant metastasis in colorectal cancer (CRC) is driven by organotropism, where cancer cells target specific organs. Understanding these molecular mechanisms is key to developing new therapies for CRC metastasis.
Area of Science:
- Oncology
- Cancer Metastasis Research
Background:
- Distant metastasis is a primary cause of mortality in colorectal cancer (CRC).
- Organotropism, the targeting of specific organs by metastasis, is a key feature of CRC, with the liver, lungs, and peritoneum being common sites.
- CRC cells release factors that facilitate organotropism before establishing premetastatic niches.
Purpose of the Study:
- To comprehensively review the molecular mechanisms underlying organotropic metastasis in colorectal cancer.
- To explore the potential of targeting organotropism for novel CRC therapeutic strategies.
Main Methods:
- Review of literature focusing on metabolic reprogramming, tumor-derived exosomes, immune system interactions, and cancer cell-organ crosstalk in CRC metastasis.
- Analysis of molecular pathways involved in the establishment of premetastatic niches and organ-specific colonization.
Main Results:
- Metabolic reprogramming influences the ability of CRC cells to colonize distant organs.
- Tumor-derived exosomes play a critical role in preparing metastatic sites.
- Immune cell interactions and cancer cell-organ crosstalk are integral to CRC organotropic metastasis.
Conclusions:
- Understanding the molecular drivers of CRC organotropic metastasis is essential for improving diagnosis and treatment.
- Targeting organotropism presents a promising therapeutic avenue for colorectal cancer patients.
- Further research into these mechanisms could lead to more effective, biomarker-based therapies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy

